Rieke E. Alten
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 173 publications
Correction to: Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients.
Journal: Rheumatology and therapy
Published: November 20, 2025
Rationale, Design and Methods of the Filgotinib Initial Response Study in Rheumatoid Arthritis (FIRST-RA).
Journal: Rheumatology and therapy
Published: October 09, 2025
Vasculitic fasciitis characterizes a distinct subset of vasculitic myopathy with interferon-gamma signature.
Journal: Acta neuropathologica
Published: August 26, 2025
Correction to: Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications.
Journal: Advances in therapy
Published: July 11, 2025
Myopathology and Immune Profile of Granulomatous Myositis in Sarcoid Myopathy.
Journal: Neuropathology and applied neurobiology
Published: April 28, 2025
Diagnostics and treatment of gout : S3 guideline of the German Society for Rheumatology and Clinical Immunology (DGRh, lead management) and participating professional societies: German Society for Internal Medicine (DGIM), German Society for General Medicine and Family Medicine (DEGAM), German Society for Nephrology (DGfN), German Society for Orthopaedic and Trauma Surgery (DGOU), German Society for Nutritional Medicine (DGEM), German Roentgen Society-Society for Medical Radiology (DRG), German Rheumatism League
Journal: Zeitschrift fur Rheumatologie
Published: February 05, 2025
Diagnostics and treatment of gout : Short version of the German S3 guideline
Journal: Zeitschrift fur Rheumatologie
Published: February 05, 2025
Long-Term Effectiveness of Baricitinib and Other b/tsDMARDs in Patients with Rheumatoid Arthritis with Early Low Disease Activity or Remission: 2-Year Data from the RA-BE-REAL Study.
Journal: Rheumatology and therapy
Published: January 08, 2025
Association Between Patient-Reported Pain and Remission or Low Disease Activity in Patients with Rheumatoid Arthritis: Data from RA-BE-REAL Prospective Observational Study.
Journal: Rheumatology and therapy
Published: August 29, 2024
Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study.
Journal: RMD open
Published: August 08, 2024
Impact of systemic inflammation and disease activity on the incidence of interstitial lung disease in patients with rheumatoid arthritis - a nested case-control study within the German biologics register RABBIT.
Journal: Arthritis research & therapy
Published: July 23, 2024
Predicting abatacept retention using machine learning.
Journal: Arthritis research & therapy
Published: July 10, 2024
Last Updated: 09/26/2026